Skip to main content
. Author manuscript; available in PMC: 2015 Aug 22.
Published in final edited form as: Leukemia. 2011 Aug 12;26(2):349–355. doi: 10.1038/leu.2011.204

Table 3.

Multivariate analysis of the ISS and the genetic groups defined by number of adverse lesions

Variable PFS OS
HR 95% CI p HR 95% CI p
Number of adverse lesions (0 vs 1) 1.48 1.21 - 1.80 <0.001 1.30 1.00 - 1.69 0.048
Number of adverse lesions (0 vs >1) 2.42 1.89 - 3.09 <0.001 2.59 1.93 - 3.47 <0.001
ISS (I vs II) 1.34 1.05 - 1.70 0.019 1.79 1.24 - 2.57 0.002
ISS (I vs III) 1.53 1.20 - 1.96 0.001 2.72 1.91 - 3.89 <0.001